loading
전일 마감가:
$2.36
열려 있는:
$0.9
하루 거래량:
508
Relative Volume:
0.01
시가총액:
$12.87M
수익:
-
순이익/손실:
$-4.74M
주가수익비율:
-1.1333
EPS:
-0.75
순현금흐름:
$-3.46M
1주 성능:
-63.98%
1개월 성능:
-69.42%
6개월 성능:
-72.76%
1년 성능:
-76.39%
1일 변동 폭
Value
$0.85
$0.90
1주일 범위
Value
$0.90
$0.90
52주 변동 폭
Value
$0.90
$12.00

Lipella Pharmaceuticals Inc Stock (LIPO) Company Profile

Name
명칭
Lipella Pharmaceuticals Inc
Name
전화
412-901-0315
Name
주소
400 N LEXINGTON ST, PITTSBURGH
Name
직원
7
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
LIPO's Discussions on Twitter

LIPO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
LIPO
Lipella Pharmaceuticals Inc
0.85 12.87M 0 -4.74M -3.46M -0.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
440.37 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
520.86 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.24 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.20 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.75 28.51B 3.81B -644.79M -669.77M -6.24

Lipella Pharmaceuticals Inc 주식(LIPO)의 최신 뉴스

pulisher
Jun 17, 2025

Lipella Pharmaceuticals Announces U.S. Patent Issuance for Diagnostic Technology - GlobeNewswire

Jun 17, 2025
pulisher
Jun 17, 2025

Lipella Pharmaceuticals announces U.S. patent issuance for diagnostic tech - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

New Patent Powers Lipella's Breakthrough: MRI Technology Could Transform Disease Detection Until 2045 - Stock Titan

Jun 17, 2025
pulisher
Jun 16, 2025

Lipella Pharmaceuticals Announces 2025 Stockholders Meeting Date - TipRanks

Jun 16, 2025
pulisher
Jun 04, 2025

LIPO Secures Continued Partnership with Cook MyoSite for Enhanced Product Development | LIPO Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Lipella Pharmaceuticals Inc. Re-Signs Manufacturing Collaboration Agreement with Cook MyoSite Inc. to Support LP-310 Clinical Development - MarketScreener

Jun 04, 2025
pulisher
Jun 04, 2025

Lipella Re-Signs Manufacturing Collaboration Agreement with Cook MyoSite - Contract Pharma

Jun 04, 2025
pulisher
Jun 04, 2025

Lipella Pharmaceuticals re-signs manufacturing collab with Cook MyoSite - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Lipella Pharmaceuticals extends manufacturing pact with Cook MyoSite - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Lipella Pharmaceuticals Re-signs Manufacturing Collaboration Agreement with Cook MyoSite to Support LP-310 Clinical Development - GlobeNewswire

Jun 04, 2025
pulisher
Jun 04, 2025

First-Ever Oral Lichen Planus Treatment Advances as Lipella Secures Key Manufacturing Deal - Stock Titan

Jun 04, 2025
pulisher
May 19, 2025

Lipella Pharmaceuticals to appeal Nasdaq noncompliance warningPittsburgh Business Times - The Business Journals

May 19, 2025
pulisher
May 16, 2025

Lipella Pharmaceuticals Faces Nasdaq Compliance Challenge - TipRanks

May 16, 2025
pulisher
May 15, 2025

LIPO: Lipella Pharmaceuticals Reports Promising Phase 2a Trial Results for LP-310 | LIPO Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Lipella Pharmaceuticals Presents Promising Phase 2a Trial Data - TipRanks

May 15, 2025
pulisher
May 15, 2025

Lipella Pharmaceuticals to Present Phase 2a Data for LP-310 - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

Breakthrough Phase 2a Data: New LP-310 Treatment Cuts Oral Lichen Planus Pain by 65%, Exceeds Endpoints - Stock Titan

May 15, 2025
pulisher
Apr 23, 2025

Analytical Overview: Lipella Pharmaceuticals Inc (LIPO)’s Ratios Tell a Financial Story - DWinneX

Apr 23, 2025
pulisher
Apr 23, 2025

Lipella Pharmaceuticals Abstract on Oral Lichen Planus - GlobeNewswire

Apr 23, 2025
pulisher
Apr 23, 2025

Clinical Data: New Treatment Breakthrough for Oral Lichen PlanusPhase 2a Trial Shows Remarkable Improvement - Stock Titan

Apr 23, 2025
pulisher
Apr 22, 2025

LIPO’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

Apr 22, 2025
pulisher
Apr 22, 2025

LIPO stock’s current quarter earnings estimates: What analysts predict? - uspostnews.com

Apr 22, 2025
pulisher
Apr 22, 2025

Lipella Reports Positive Results from Second Cohort in LP-310 Phase 2a Trial for Oral Lichen Planus - Reuters

Apr 22, 2025
pulisher
Apr 22, 2025

Lipella Pharmaceuticals announces results from second cohort of LP-310 trial - TipRanks

Apr 22, 2025
pulisher
Apr 22, 2025

Lipella Reports Positive Phase 2a Results from Second - GlobeNewswire

Apr 22, 2025
pulisher
Apr 22, 2025

Clinical Trial Breakthrough: New Oral Lichen Planus Treatment Shows 65% Pain Reduction, Multiple Endpoint Success - Stock Titan

Apr 22, 2025
pulisher
Apr 17, 2025

Lipella Pharmaceuticals (LIPO) Stock Price, News & Analysis - MarketBeat

Apr 17, 2025
pulisher
Apr 14, 2025

Lipella Pharmaceuticals regains Nasdaq compliance By Investing.com - Investing.com Canada

Apr 14, 2025
pulisher
Apr 14, 2025

Lipella Pharmaceuticals regains Nasdaq compliance - Investing.com Australia

Apr 14, 2025
pulisher
Apr 10, 2025

Lipella Pharmaceuticals expands preferred stock class - Investing.com Australia

Apr 10, 2025
pulisher
Apr 09, 2025

Lipella Pharmaceuticals stock hits 52-week low at $2 By Investing.com - Investing.com Canada

Apr 09, 2025
pulisher
Apr 09, 2025

Lipella Pharmaceuticals expands preferred stock class By Investing.com - Investing.com South Africa

Apr 09, 2025
pulisher
Apr 09, 2025

Lipella Pharmaceuticals stock hits 52-week low at $2 - Investing.com

Apr 09, 2025
pulisher
Apr 08, 2025

Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus - The Manila Times

Apr 08, 2025
pulisher
Apr 08, 2025

Clinical Trial Success: Lipella's Novel OLP Treatment Shows Encouraging Results in Phase 2a Study - Stock Titan

Apr 08, 2025
pulisher
Apr 02, 2025

Virtu Financial LLC Acquires Shares of 13,310 Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) - Defense World

Apr 02, 2025
pulisher
Mar 31, 2025

Lipella Pharmaceuticals Co-Founder Michael Chancellor Featured on the Pharmaverse Podcast - The Globe and Mail

Mar 31, 2025
pulisher
Mar 31, 2025

Clinical Trial Success: Lipella's 40-Year Veteran Shares Breakthrough Journey in Exclusive Interview - Stock Titan

Mar 31, 2025
pulisher
Mar 28, 2025

Tariffs and Tech Troubles Weigh on Markets - The Globe and Mail

Mar 28, 2025
pulisher
Mar 28, 2025

Lipella Pharmaceuticals Inc. (LIPO) reports earnings - Quartz

Mar 28, 2025
pulisher
Mar 28, 2025

LIPELLA PHARMACEUTICALS INC. SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 26, 2025

Analysts Are Bullish on Top Healthcare Stocks: Quince Therapeutics (QNCX), Lucid Diagnostics (LUCD) - The Globe and Mail

Mar 26, 2025
pulisher
Mar 13, 2025

Spartan Capital Securities, LLC Proudly Serves as the Sole Agent in Lipella Pharmaceuticals Inc. - Ukraine Business Journal

Mar 13, 2025
pulisher
Mar 08, 2025

Lipella Pharmaceuticals stock hits 52-week low at $2.21 - Investing.com Australia

Mar 08, 2025
pulisher
Mar 07, 2025

Spartan Capital Securities, LLC Announces Key February Transactions - The Manila Times

Mar 07, 2025
pulisher
Mar 07, 2025

Spartan Capital Securities, LLC Announces Key February Transactions - GlobeNewswire Inc.

Mar 07, 2025

Lipella Pharmaceuticals Inc (LIPO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.55
price down icon 0.20%
$35.81
price down icon 0.59%
$20.90
price up icon 1.12%
$101.52
price up icon 0.63%
$106.96
price up icon 0.34%
biotechnology ONC
$240.93
price down icon 0.50%
자본화:     |  볼륨(24시간):